Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre

被引:58
作者
Bruno, B
Souillet, G
Bertrand, Y
Werck-Gallois, MC
Satta, AS
Bellon, G
机构
[1] Debrousse Hosp, Dept Paediat Haematol, Lyon, France
[2] Debrousse Hosp, Resp Lab, Lyon, France
关键词
pulmonary function; graft versus host disease; total body irradiation; busulphan; cytomegalovirus;
D O I
10.1038/sj.bmt.1704549
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We retrospectively reviewed the results of serial pulmonary function tests (PFT) after allogeneic bone marrow transplantation (BMT) performed in 80 children at a single institution over a 16-year period. We looked for associations linking PFT results to graft-versus-host disease (GVHD), conditioning regimen ( total body irradiation (TBI) vs busulphan), and cytomegalovirus immune status. The median follow-up after BMT was 4 years. At 2 years after BMT, significant declines were found in forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1), as compared to baseline. Both FEV1 and the FEV1/FVC ratio showed significantly greater reductions in the group conditioned with busulphan (n = 22) than in the group conditioned with TBI (n = 49) and were significantly lower in the patients with (n = 16) than without (n = 64) chronic GVHD. Busulphan may be associated with greater long-term lung toxicity than TBI. The relevance of this finding to selection of conditioning regimens for BMT should be examined in the light of the overall pattern of side effects. Chronic GVHD was associated with airway obstruction.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 35 条
[1]  
BARRETT A, 1984, Experimental Hematology (Charlottesville), V12, P6
[2]   Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens [J].
Bleyzac, N ;
Souillet, G ;
Magron, P ;
Janoly, A ;
Martin, P ;
Bertrand, Y ;
Galambrun, C ;
Dai, Q ;
Maire, P ;
Jelliffe, RW ;
Aulagner, G .
BONE MARROW TRANSPLANTATION, 2001, 28 (08) :743-751
[3]  
BURNS WA, 1970, AM REV RESPIR DIS, V101, P408
[4]   Late pulmonary sequelae after childhood bone marrow transplantation [J].
Cerveri, I ;
Zoia, MC ;
Fulgoni, P ;
Corsico, A ;
Casali, L ;
Tinelli, C ;
Zecca, M ;
Giorgiani, G ;
Locatelli, F .
THORAX, 1999, 54 (02) :131-135
[5]   OBSTRUCTIVE LUNG-DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION - CLINICAL PRESENTATION AND COURSE [J].
CLARK, JG ;
CRAWFORD, SW ;
MADTES, DK ;
SULLIVAN, KM .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (05) :368-376
[6]   RISK-FACTORS FOR AIR-FLOW OBSTRUCTION IN RECIPIENTS OF BONE-MARROW TRANSPLANTS [J].
CLARK, JG ;
SCHWARTZ, DA ;
FLOURNOY, N ;
SULLIVAN, KM ;
CRAWFORD, SW ;
THOMAS, ED .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :648-656
[7]  
COOPER JAD, 1986, AM REV RESPIR DIS, V133, P321
[8]  
CURTIS DJ, 1995, BONE MARROW TRANSPL, V16, P169
[9]  
De Marco R, 1996, Eur J Ophthalmol, V6, P436
[10]  
DEEG HJ, 1986, BONE MARROW TRANSPL, V1, P151